The IRS is scrutinizing how UnitedHealth moved money through foreign subsidiaries—and whether it underpaid taxes
The IRS is examining UnitedHealth's transactions with foreign subsidiaries for potential tax underpayment. The dispute centers on transfer pricing, where the IRS may adjust taxable income if transactions between related businesses are deemed unfairly priced. UnitedHealth's gross unrecognized tax benefits rose to $5.6 billion in 2025, but the company did not attribute this to the dispute. The IRS and UnitedHealth declined to comment on the specifics.
How this was made
The 30-second read
Why it matters
UnitedHealth's $5.6B tax reserve may not reflect this specific dispute, but the IRS examination adds uncertainty.
Market read
IRS scrutiny introduces tax risk for UnitedHealth, potentially influencing its stock price.
What to watch
Potential offset by existing tax reserves and ongoing litigation outcomes.
Background
Transfer pricing disputes can involve billions in tax adjustments, as seen with Coca-Cola and Meta.
Ticker impact
IRS is examining UnitedHealth's transfer pricing and may adjust taxable income, creating tax risk.
Downside pressure if adjustments are significant.
IRS scrutiny often leads to higher tax liabilities; uncertainty around exposure adds risk.
Market effects
Highlights transfer pricing risk for large health insurers.
May affect US healthcare sector sentiment.
Sets precedent for IRS scrutiny of multinational health firms.
Counterpoint
IRS action could be a negotiating tactic; actual impact may be limited.
Key entities
- CompanyUnitedHealth Group
US health insurer facing IRS transfer pricing scrutiny.
